Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe
- 18 March 2011
- Vol. 66 (8), 1114-1121
- https://doi.org/10.1111/j.1398-9995.2011.02577.x
Abstract
To cite this article: Stalder J‐F, Barbarot S, Wollenberg A, Holm EA, De Raeve L, Seidenari S, Oranje A, Deleuran M, Cambazard F, Svensson A, Simon D, Benfeldt E, Reunala T, Mazereeuv J, Boralevi F, Kunz B, Misery L, Mortz CG, Darsow U, Gelmetti C, Diepgen T, Ring J, Moehrenschlager M, Gieler U, Taïeb A, for the PO‐SCORAD Investigators Group. Patient‐Oriented SCORAD (PO‐SCORAD): a new self‐assessment scale in atopic dermatitis validated in Europe. Allergy 2011; 66: 1114–1121. Abstract Background: Patient‐oriented medicine is an emerging concept, encouraged by the World Health Organization, to greater involvement of the patient in the management of chronic diseases. The Patient‐Oriented SCORing Atopic Dermatitis (PO‐SCORAD) index is a self‐assessment score allowing the patient to comprehensively evaluate the actual course of atopic dermatitis (AD), using subjective and objective criteria derived mainly from the SCORAD, a validated AD severity clinical assessment tool. Objectives: To validate the PO‐SCORAD index in a large European population of patients exhibiting all forms of AD severity by assessing its correlation with the SCORAD index. Patients/methods: Four hundred and seventy‐one patients (185 adults, 286 children) consulting for AD in hospitals from 9 European countries were recruited. The investigators and the patients used the SCORAD and PO‐SCORAD scales, respectively, to assess AD severity at inclusion (D0) and 28 ± 7 days later (D28). Results: Patient‐Oriented SCORing Atopic Dermatitis and SCORAD scores were significantly correlated at D0 [r = 0.67 (95% CI: 0.62; 0.72), P < 0.0001]. Consistency was confirmed at D28, with a stronger linear correlation between both scales [r = 0.79 (95% CI: 0.75; 0.83), P < 0.0001]. Absolute changes from baseline in SCORAD and PO‐SCORAD scores were also significantly correlated [r= 0.71 (95% CI: 0.64; 0.76), P < 0.0001]. Although no specific intervention was investigated, AD improved over the study, with a decrease of PO‐SCORAD and SCORAD scores from D0 to D28 by −19.19% and −24.39%, respectively. The consistency of the correlations was similar in the adult and children groups. Conclusions: This study validated the use of PO‐SCORAD to self‐assess AD severity and demonstrated its good correlation with SCORAD.Keywords
This publication has 19 references indexed in Scilit:
- Useful Tools for the Management of Atopic DermatitisAmerican Journal of Clinical Dermatology, 2009
- Management of Atopic Dermatitis in the Pediatric PopulationPediatrics, 2008
- Change in prevalence of atopic dermatitis between 1986 and 2001 among childrenAllergy and Asthma Proceedings, 2008
- The Socioeconomic Impact of Atopic Dermatitis in the United States: A Systematic ReviewPediatric Dermatology, 2008
- Dermatite atopique : un référentiel d’éducation du maladeAnnales de Dermatologie et de Vénéréologie, 2007
- Pediatric Atopic Eczema: The Impact of an Educational InterventionPediatric Dermatology, 2006
- Atopic DermatitisNew England Journal of Medicine, 2005
- Atopic dermatitisThe Lancet, 2003
- Clinical Validation and Guidelines for the SCORAD Index: Consensus Report of the European Task Force on Atopic DermatitisDermatology, 1997
- Severity Scoring of Atopic Dermatitis: The SCORAD IndexDermatology, 1993